New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
09:59 EDTPAY, THR, MIND, KMB, GNW, ESV, DTV, DB, CHA, CTL, AZN, ARCP, MO, ATKOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: ATK (ATK) downgraded to Neutral from Buy at Goldman... Altria Group (MO) downgraded to Market Perform from Outperform at Wells Fargo... American Realty (ARCP) downgraded to Neutral from Outperform at RW Baird... AstraZeneca (AZN) downgraded to Market Perform from Outperform at Leerink... CenturyLink (CTL) downgraded to Equal Weight from Overweight at Morgan Stanley... China Telecom (CHA) downgraded to Neutral from Buy at Goldman... Deutsche Bank (DB) downgraded to Underperform from Neutral at BofA/Merrill... DirecTV (DTV) downgraded to Hold from Buy at Wunderlich... Ensco (ESV) downgraded to Hold from Buy at Jefferies... Genworth (GNW) downgraded to Underweight from Equal Weight at Morgan Stanley... Kimberly Clark (KMB) downgraded to Hold from Buy at Argus... Mitcham Industries (MIND) downgraded to Accumulate from Buy at Global Hunter... Thermon Group (THR) downgraded to Hold from Buy at KeyBanc... VeriFone (PAY) downgraded to Neutral from Positive at Susquehanna.
News For ATK;MO;ARCP;AZN;CTL;CHA;DB;DTV;ESV;GNW;KMB;MIND;THR;PAY From The Last 14 Days
Check below for free stories on ATK;MO;ARCP;AZN;CTL;CHA;DB;DTV;ESV;GNW;KMB;MIND;THR;PAY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 26, 2014
13:17 EDTMOWHO calls on countries to restrict e-cigarette use, NY Times says
Subscribe for More Information
12:16 EDTMOCourt rules Philip Morris must protect itself against suit, Bloomberg says
An appeals court ruled that Philip Morris USA, a unit of Altria Group, needs to protect itself against a whistle-blower case regarding military cigarette pricing, according to Bloomberg, citing comments that U.S. Circuit Judge Cornelia wrote for a three-panel judge. The ruling rejects the company's allegation that the case didn't cite new data. Reference Link
August 25, 2014
14:46 EDTDTVDirecTV, NFL have outline for Sunday Ticket deal, SBJ says
Subscribe for More Information
11:48 EDTDTVAT&T, DirecTV agree to deal with DOJ paving way for merger, NY Post says
AT&T (T) has agreed with the Justice Department on terms paving the way for it to acquire DirecTV (DTV), though it could not be learned what, if any, conditions the department has placed on the merger, according to The New York Post, citing a source close to the process. Reference Link
06:29 EDTAZNPfizer mulls possible AstraZeneca offer options, FT says
Subscribe for More Information
August 22, 2014
10:07 EDTAZNOptions with increasing implied volatility: ORPH EXAS AZN
Subscribe for More Information
05:19 EDTAZNStocks with implied volatility movement; JRJC AZN
Subscribe for More Information
August 21, 2014
12:50 EDTDBDeutsche Bank divests natgas trading book to Morgan Stanley, Reuters says
Subscribe for More Information
12:00 EDTMOAltria Group raises quarterly dividend by 8.3% to 52c from 48c
Subscribe for More Information
09:57 EDTCTLRumor: CenturyLink moves up on speculation it could spin-off assets into a REIT
Subscribe for More Information
09:54 EDTAZNPotential Pfizer, AstraZeneca deal seen around year-end, Reuters says
Investors and analysts see Pfizer (PFE) making another attempt to acquire AstraZeneca (AZN) around year-end, even though talks between the two can resume on August 26 per British takeover rules, Reuters reports. Reference Link
07:47 EDTAZNPfizer looking at new targets, including Actavis, Bloomberg reports
While it weighs another attempt to acquire AstraZeneca (AZN), Pfizer is considering other overseas alternatives, including Actavis (ACT), Bloomberg reports, citing people familiar with the matter. Pfizer prefers to reach a deal with AstraZeneca, and a move on another company is unlikely "anytime soon," Bloomberg adds, citing its sources. Shares of Actavis are rising 3%, or $6.65, to $230.01 in pre-market trading, while AstraZeneca is up 2% to $72.59. Reference Link
05:42 EDTAZNIllumina announces strategic partnership with AstraZeneca, Sanofi, Janssen
Illumina (ILMN) announced it has formed collaborative partnerships with leading pharmaceutical companies to develop a universal next-generation sequencing, or NGS,-based oncology test system. The system will be used for clinical trials of targeted cancer therapies with a goal of developing and commercializing a multi-gene panel for therapeutic selection, resulting in a more comprehensive tool for precision medicine. Initial strategic partners include AstraZeneca (AZN), Janssen Biotech, a Johnson & Johnson (JNJ) company, and Sanofi (SNY). Illumina is working with the strategic partners to develop assays that detect and measure multiple variants simultaneously to support partners’ clinical trials, with the objectives of securing regulatory agency approvals and test commercialization. In parallel, Illumina is working with key thought leaders to set standards for NGS-based assays in routine clinical oncology practice, as well as to define regulatory frameworks to enable this new testing paradigm. Together, Illumina and its strategic partners aim to transition from single-analyte companion diagnostics to panel-based assays that select for “companion therapeutics.”
August 20, 2014
08:41 EDTCHANQ Mobile's vLife Technnology adopted by China Telecom
NQ Mobile (NQ) announced a partnership with China Telecom (CHA) that will bring NQ Mobile's vLife technology to China Telecom's "E Surfing" product. Under terms of the agreement, vLife will power the user interface for the mobile cloud platform.
August 19, 2014
07:01 EDTAZNDOJ closes investigation into PLATO Brilinta clinical trial, plans no action
AstraZeneca today announced that it has received confirmation from the United States Department of Justice that it is closing its investigation into PLATO, a clinical trial with BRILINTA tablets. The government is not planning any further action. Pascal Soriot, CEO, said: “We welcome the Department of Justice’s decision not to pursue further action. We have always had absolute confidence in the integrity of the PLATO trial and we are proud of the important benefit BRILINTA offers to patients around the world suffering from acute coronary syndrome. As one of AstraZeneca’s growth platforms, we remain committed to delivering the full potential of this important medicine.” As part of our continued commitment to advancing the science behind cardiovascular medicine, AstraZeneca has initiated a clinical trial program for BRILINTA, its largest program involving more than 80,000 patients worldwide.
August 18, 2014
09:20 EDTDBDeutsche Bank appoints Shannon Americas Chief Information Officer
Subscribe for More Information
09:16 EDTDTVDreamWorks Animation appoints Fazal Merchant as CFO effective September 15
Subscribe for More Information
07:57 EDTAZNCambridge Healthtech Institute to hold a summit
6th Annual Bioprocessing Summit to be held in Boston on August 18-22.
August 15, 2014
08:29 EDTCHAChina Telecom now hosting Apple iCloud data in China, Marbridge Daily says
Apple (AAPL), which had previously been storing iCloud data for its Chinese users on servers in the U.S., in reportedly using China Telecom (CHA) as its sole cloud storage services provider in China, according to online Chinese media reports, said Marbridge Daily, citing Sina Tech. Apple and China Telecom have not commented, the report noted. Reference Link
06:51 EDTDBDeutsche Bank settles $810M RMBS case with BayernLB, Reuters says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use